NEW YORK (GenomeWeb) – The National Institute on Drug Abuse is offering researchers free genotyping services for existing extracted DNA samples from individuals with substance abuse disorders, the National Institutes of Health announced last week.
According to the NIDA, the Center for Genetic Studies at the Rutgers University-based biorepository RUCDR Infinite Biologics will genotype samples submitted on BioRealm's SmokeScreen Genotyping array.
The resulting data will be stored in the National Center of Biotechnology Information's database of Genotypes and Phenotypes for six months, during which time the investigators who submitted the samples will be able to analyze their data. After this period, the data will be publicly released per the NIH's Genome Data Sharing Policy.
Requests for genotyping must be received no later than April 1, and proposed samples must be approved by the NIDA, the NIH said. Additional details can be found here.